Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
MDMA
Biotech
JPM's private capital team ‘actively looking’ at psychedelics
With the stage set for the first psychedelic-based therapy to nab FDA approval, even J.P. Morgan can't resist the allure.
Max Bayer
Feb 28, 2024 7:00am
Psychedelic biotech MAPS PBC rebrands to Lykos, snags $100M
Jan 5, 2024 10:50am
First-ever drug application for MDMA finally reaches FDA
Dec 13, 2023 9:39am
Psychiatry biotech hopes to Transcend PTSD rivals with new data
Dec 5, 2023 5:45pm
Psychedelics and the next frontier of mental healthcare
Nov 10, 2023 6:00am
MDMA approval filing nears after drug hits again in phase 3
Sep 15, 2023 9:28am